Successful sublingual immunotherapy for severe egg allergy in children: a case report

• Published in: Allergy, asthma, and clinical immunology asthma, and clinical immunology, 2021-01, Vol.17 (1), p.2-2, Article 2
• Main Authors: Sagara, Nagatoshi, Fujita, Satoshi, Suzuki, Ryohei, Aota, Akiko, Akashi, Kenichi, Katsunuma, Toshio
• Format: Article
• Language: English
• Subjects: Age; Allergens; Anaphylaxis; Antigens; Asthma; Case Report; Case reports; Drug therapy; Egg; Eggs; Epinephrine; Food allergies; Food allergy; Health aspects; Immunoglobulin E; Immunoglobulins; Immunotherapy; Medical research; Medicine, Experimental; Patients; Pediatrics; Pruritus; Sublingual immunotherapy; Urticaria
• ISSN: 1710-1484; 1710-1492; 1710-1492
• DOI: 10.1186/s13223-020-00506-1

Egg allergy is one of the most common food allergies in children. To date, oral immunotherapy (OIT) has been considered as a promising treatment option for egg allergy. However, safety issues remain concerning severe adverse events requiring epinephrine injection. Hence, establishing a safer method to treat egg allergy would be beneficial. We report here two children with egg allergy who were safely treated with sublingual immunotherapy (SLIT) before transitioning to OIT. Patient 1 was a 7-year-old girl and Patient 2 was a 5-year-old girl. Although OIT for egg had been attempted in both patients, severe anaphylactic symptoms were induced by ingesting only 0.1 g of heated whole egg. Therefore, SLIT was conducted with aqueous suspensions consisting of water and heated whole egg powder. Suspensions were administered sublingually, kept in the mouth for 2 min, and spat out immediately thereafter. SLIT was continued for 7 months for Patient 1 and 8 months for Patient 2 due to the exploratory character of the study. Afterwards, the patients successfully transferred to low-dose OIT with 1 g of heated whole egg (≒170 mg of egg protein) daily, and are continuing the therapy as of June 2020. As for adverse reactions, Patient 1 expressed oral cavity itchiness once at the beginning of SLIT. Patient 2 had no adverse reaction. The levels of antigen-specific IgE decreased in both patients after SLIT, and further decreased after switching to OIT. Few clinical studies have evaluated the efficacy and safety of SLIT for egg allergy. Although the treatment was conducted in only two patients, our results have shown that SLIT is a promising treatment procedure for egg allergy. Further clinical trials will be needed to additionally assess the efficacy and safety of SLIT in children with food allergy.